BGR GOVERNMENT AFFAIRS

Lobbying for UROGEN PHARMA, INC. · Biopharmaceutical company

Filing 4th Quarter - Report (No Activity)

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.